Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
45.72
+0.94 (2.10%)
Nov 21, 2024, 11:13 AM EST - Market open
Enovis Revenue
Enovis had revenue of $505.22M in the quarter ending September 27, 2024, with 21.00% growth. This brings the company's revenue in the last twelve months to $2.00B, up 20.52% year-over-year. In the year 2023, Enovis had annual revenue of $1.71B with 9.22% growth.
Revenue (ttm)
$2.00B
Revenue Growth
+20.52%
P/S Ratio
1.23
Revenue / Employee
$305,598
Employees
6,550
Market Cap
2.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
Dec 31, 2019 | 3.33B | 1.13B | 51.73% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Seaboard | 8.90B |
Insperity | 6.55B |
ArcBest | 4.27B |
Energizer Holdings | 2.89B |
HNI Corporation | 2.56B |
ATS Corporation | 2.11B |
ICF International | 2.00B |
AZZ Inc. | 1.57B |
ENOV News
- 2 days ago - Enovis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Enovis Announces Third Quarter 2024 Results - GlobeNewsWire
- 6 weeks ago - Enovis to Host Third Quarter 2024 Results Conference Call on November 6th - GlobeNewsWire
- 6 weeks ago - Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says - Benzinga
- 2 months ago - Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies - GlobeNewsWire
- 3 months ago - Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures - GlobeNewsWire
- 3 months ago - Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability - GlobeNewsWire